Is DGX or FLGT more undervalued in 2026?

CirclFi compares Quest Diagnostics Incorporated (DGX) and Fulgent Genetics, Inc. (FLGT) using 13 institutional-grade valuation models. DGX has a Quality of Company score of 8.5/10 while FLGT scores 7.1/10.

Which is a better buy — DGX or FLGT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DGX and FLGT valuations compare?

DGX at $196.20 and FLGT at $18.24 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DGX vs FLGT Valuation Comparison 2026 — Intrinsic Value Analysis

DGX

Diagnostics & Research

Quest Diagnostics Incorporated

Quality

8.5

out of 10

Value Trap

SAFE

Price

$196.20

Last close

Models

13/13

Active

FLGT

Diagnostics & Research

Fulgent Genetics, Inc.

Quality

7.1

out of 10

Value Trap

SAFE

Price

$18.24

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	DGX Fair Value	DGX Upside	FLGT Fair Value	FLGT Upside
Bayesian DCF	Intrinsic	$115.72	-41.0%	$62.09	+240.4%
Earnings Power Value	Intrinsic	$30.73	-84.3%	$24.12	+32.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DGX vs FLGT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DGX vs FLGT — Which Stock Is More Undervalued?

DGX scores higher with a 8.5/10 quality rating vs FLGT's 7.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Quest Diagnostics Incorporated (DGX) and Fulgent Genetics, Inc. (FLGT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DGX currently trades at $196.20 with a QOC of 8.5/10, while FLGT trades at $18.24 with a QOC of 7.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).